misonneh's Flockhart:DA [11 articles] Export

Recent papers posted to misonneh's library by the author Flockhart:DA. You can also see everyone's Flockhart:DA.

	Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. [My Copy] Pharmacogenetics, Vol. 9, No. 5. (October 1999), pp. 539-549. by H. G. Xie, C. M. Stein, R. B. Kim, G. R. Wilkinson, D. A. Flockhart, A. J. Wood posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 12:00:28 as
	Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. [My Copy] Journal of the National Cancer Institute, Vol. 95, No. 23. (3 December 2003), pp. 1758-1764. by Vered Stearns, Michael D. Johnson, James M. Rae, et al.Alan Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes, Zeruesenay Desta, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism ddi breast by misonneh on 2009-10-27 07:02:30 as
	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. [My Copy] Journal of the National Cancer Institute, Vol. 97, No. 1. (5 January 2005), pp. 30-39. by Yan Jin, Zeruesenay Desta, Vered Stearns, et al.Bryan Ward, Herbert Ho, Kyung-Hoon H. Lee, Todd Skaar, Anna Maria M. Storniolo, Lang Li, Adjei Araba, Rebecca Blanchard, Anne Nguyen, Lynda Ullmer, Jill Hayden, Suzanne Lemler, Richard M. Weinshilboum, James M. Rae, Daniel F. Hayes, David A. Flockhart posted to tamoxifen pharmacogenetics genetics ddi cyp2d6 breast by misonneh on 2009-10-27 07:01:49 as along with 1 person frohike
	Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. [My Copy] Clinical pharmacology and therapeutics, Vol. 80, No. 1. (July 2006), pp. 61-74. by Silvana Borges, Zeruesenay Desta, Lang Li, et al.Todd C. Skaar, Bryan A. Ward, Anne Nguyen, Yan Jin, Anna Maria M. Storniolo, D. Michele Nikoloff, Lin Wu, Grant Hillman, Daniel F. Hayes, Vered Stearns, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism cyp2d6 breast by misonneh on 2009-10-27 07:01:06 as
	Germline pharmacogenetics of tamoxifen response: have we learned enough? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5147-5149. by Zeruesenay Desta, David A. Flockhart posted to tamoxifen pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-10-27 06:59:30 as
	Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. [My Copy] Breast cancer research and treatment, Vol. 115, No. 3. (June 2009), pp. 643-650. by Adedayo A. Onitilo, Catherine A. McCarty, Russell A. Wilke, et al.Ingrid Glurich, Jessica M. Engel, David A. Flockhart, Anne Nguyen, Lang Li, Deming Mi, Todd C. Skaar, Yan Jin posted to tamoxifen pharmacogenetics hr genetics breast adr by misonneh on 2009-10-21 02:21:36 as
	Pharmacogenomics: challenges and opportunities. [My Copy] Annals of internal medicine, Vol. 145, No. 10. (21 November 2006), pp. 749-757. by Dan M. Roden, Russ B. Altman, Neal L. Benowitz, et al.David A. Flockhart, Kathleen M. Giacomini, Julie A. Johnson, Ronald M. Krauss, Howard L. McLeod, Mark J. Ratain, Mary V. Relling, Huijun Z. Ring, Alan R. Shuldiner, Richard M. Weinshilboum, Scott T. Weiss, Pharmacogenetics Research Network posted to review pharmacogenetics perspective adr by misonneh on 2009-09-29 18:13:22 as along with 1 person guhjy
	A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypes. [My Copy] Journal of biopharmaceutical statistics, Vol. 18, No. 6. (November 2008), pp. 1150-1177. by L. Li, M. Yu, R. D. Jason, et al.C. Shen, F. Azzouz, H. L. McLeod, S. Borges-Gonzales, A. Nguyen, T. Skaar, Z. Desta, C. J. Sweeney, D. A. Flockhart posted to gxe gxg modeling pharmacogenetics phenotype by misonneh on 2009-07-07 02:47:00 as
	Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing? [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 7, No. 2. (February 2009), pp. 203-213. by M. J. Higgins, J. M. Rae, D. A. Flockhart, D. F. Hayes, V. Stearns posted to comments cyp2d6 pharmacogenetics tamoxifen by misonneh on 2009-04-14 06:20:53 as along with 1 person dbs
	Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. [My Copy] Clinical pharmacology and therapeutics, Vol. 83, No. 5. (May 2008), pp. 702-710. by N. I. Ntukidem, A. T. Nguyen, V. Stearns, et al.M. Rehman, A. Schott, T. Skaar, Y. Jin, P. Blanche, L. Li, S. Lemler, J. Hayden, R. M. Krauss, Z. Desta, D. A. Flockhart, D. F. Hayes, Consortium on Breast Cancer Pharmacogenomics posted to breast esr1 estrogen tamoxifen by misonneh on 2009-01-23 08:35:35 as along with 1 person and 1 group Zephyrus Breast Cancer Reading Club
	Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. [My Copy] Clinical Cancer Research, Vol. 14, No. 18. (15 September 2008), pp. 5864-5868. by M. P. Goetz, V. J. Suman, F. J. Couch, et al.M. M. Ames, J. M. Rae, M. G. Erlander, X. J. Ma, D. C. Sgroi, C. A. Reynolds, W. L. Lingle, R. M. Weinshilboum, D. A. Flockhart, Z. Desta, E. A. Perez, J. N. Ingle posted to breast cyp2d6 resistance tamoxifen by misonneh on 2008-11-19 05:16:43 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/author/Flockhart:DA

review	322
breast	263
genetics	175
epigenetics	162
methylation	153
pharmacogenetics	147
statistics	90
gwas	69
gene_specific_methylation	66
comments	65
biomarker	65
prognosis	61
association	59
meta_analysis	57
tamoxifen	53
chemotherapy	50
peripheral	47
moa	47
gxe	47
diet	43
folate	40
modeling	38
response	38
survival	36
resistance	36
guideline	35
prediction	33
global	33
adr	31
epidemiology	31
epistasis	30
prostate	28
korean	28
time_to_event	28
dynamic	28
technology	27
diagnosis	26
haplotype	26
cyp2d6	25
race	24
expression	23
neoadjuvant	22
database	21
colon	21
prevention	21
circ_dna	21
instability	21
environment	20
progression	19
phenotype	18
perspective	17
pooling	17
lung	17
risk_factor	17
clinic	16
line1	16
therapy	16
immunity	15
target_dna	14
invivo	13
1-carbon	13
randomized_controlled_trial	13
hr	13
kfdap_112909	13
tool	13
tutorial	12
age	12
5mdc	12
pk	11
mirna	11
data_mining	11
metastasis	11
gxg	11
hematology	11
design	11
estrogen	10
bladder	10
pathway	9
mdr1	9
exposure	9
her2	9
smoking	9
hormone	9
reproductive	8
esr1	8
fda	8
methodology	8
lifestyle	8
heterogeneity	8
cyp450	8
epilepsy	8
bias	8
cancer	8
gst	8
ivive	8
etiology	7
power	7
cnv	7
prenatal	7
hla	7
kim_	7
mthfr	7
trend	7
dnmt	7
subtypes	7
metabolism	7
drug_discovery	6
summary	6
system_biology	6
hyper_hypo	6
alcohol	6
cell	6
pcb	6
cohort	6
histone	6
maternal	6
dna_repair	6
carbamazepine	6
ddi	6
inheritance	5
fundamental_concept_s1	5
chemoprevention	5
mortality	5
benign	5
mgmt	5
array	5
translation	5
microarray	5
mhc	5
pet	5
nos3	5
intervention	5
cervix	5
ntissue	4
disparities	4
observation	4
leukemia	4
detection	4
bmd	4
balanced	4
cns	4
refractory	4
population	4
pathology	4
triple-negative	4
bayesian	4
cimp	4
basal-like	4
transport	4
biobank	4
linkage	4
tsnp	4
asian_populations	4
public	3
toxicity	3
fu	3
practice	3
ros	3
ovarian	3
cyp1a1	3
antioxidant	3
demethylation	3
cytokine	3
swog	3
12lecture	3
cluster	3
intrauterine	3
mds	3
sult1e1	3
glioblastoma	3
molecular	3
metformin	3
sult1a1	3
statin	3
validation	3
risk_assessment	3
hitchhiking	3
aml	3
egfr_pathway	3
protocol	2
pharmacogenomics	2
fprp	2
decitabine	2
specimen	2
pharmacodynamic	2
classification	2
phase	2
isoflavone	2
testicular	2
genotype	2
polycomb	2
ugt	2
nutrition	2
diabetes	2
tpmt	2
immortalization	2
radiotherapy	2
oral	2
wnt	2
quantitative_traits	2
anthracycline	2
brain	2
finasteride	2
consorcium	2
ovary	2
lymphoma	2
grail	2
toxicology	2
bisphenol	2
caret	2
iron	2
feature_selection	2
slco1b1	2
s8897	2
key	2
hematopoiety	2
ki67	2
irinotecan	2
aromatase_inhibitor	2
mnsod	2
brca12	2
parent_study	2
comt	2
cyp2c19	2
kawasaki	2
allergy	2
epigenetic_therapy	2
insilico	2
cyp2e1	2
apoptosis	2
childhood	2
benzopyrene	2
brca	2
definition	2
endometrix	2
atm	2
nqo1	2
aspirin	2
lactation	1
compliance	1
meta_anlaysis	1
fastsnp	1
myc	1
multiple_myeloma	1
aldh1	1
temozolomide	1
illumina	1
prevalence	1
journal_club	1
pax2	1
endpoint	1
twin_study	1
xrcc3	1
cml	1
decision	1
benzene	1
aldh2	1
read_	1
histology	1
cell_cycle_control	1
paternal	1
sat2	1
mbd2	1
interleukin	1
ho1	1
xrcc1	1
liver	1
rank	1
acs	1
gpx1	1
cyp1a2	1
ugt1a1	1
methotrexate	1
dag	1
series	1
resonse	1
silencing_rna	1
cyp2c9	1
history	1
s100p	1
psychoses	1
fmr1	1
5-alpha_reductase	1
rcc	1
nhs	1
sfrp5	1
steroid	1
azacitidine	1
catechol	1
obesity	1
tgf	1
consortium	1
cyp3a4	1
dcic	1
peakbmd	1
nrf2	1
oralscc	1
cyp1b1	1
mrp3	1
maspin	1
nsaid	1
gstp1	1
osteoporosis	1
inflammtion	1
opg	1
assay	1
phytoestrogen	1
lipidadjust	1
mining	1
cbr3	1
antidepressant	1
scn	1
rfc	1
meternal	1
hnscc	1
cisplatin	1
polyphenol	1
hogg1	1
confounder	1
cyclophosphamide	1
mpo	1
parity	1
oncotypedx	1
cdk	1
alternative	1
tp53	1
nuclear_receptor	1
alkylating_agents	1
stromal_component	1
tea	1
cat	1
infection	1
abacavir	1
digoxin	1
p53	1
metabolomics	1
index	1
ecadherin	1
xpd	1
polymapr	1
plink	1
mapping	1
family_hx	1
sputum	1
src	1
networking	1
glioma	1
neurod1	1
proression	1
bmp	1
splicing	1
hpv	1
fun	1
no	1
invitro	1
peripheral_blood	1
qsar	1
diganosis	1
example	1
multitest	1
cyp19	1
casp8	1
integration	1
pharmacokinetic_variability	1
heritability	1
hif1a	1
tgm2	1
outcome	1
warfarin	1
immunoprecipitation	1

misonneh's Flockhart:DA [11 articles] Export

misonneh's tags